Chemcon Speciality Chemicals Limited (CHEMCON.NS)
- Previous Close
206.95 - Open
208.99 - Bid --
- Ask --
- Day's Range
205.60 - 214.57 - 52 Week Range
160.00 - 298.30 - Volume
55,320 - Avg. Volume
53,456 - Market Cap (intraday)
7.637B - Beta (5Y Monthly) -0.26
- PE Ratio (TTM)
32.57 - EPS (TTM)
6.40 - Earnings Date Aug 1, 2025 - Aug 5, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Aug 22, 2022
- 1y Target Est
--
Chemcon Speciality Chemicals Limited engages in the manufacture and sale of speciality chemicals for pharmaceutical, agro-chemical, and engineering and oilfield chemicals industries in India and internationally. The company offers oilfield chemicals, including calcium bromide liquid, calcium bromide powder, sodium bromide solution, and zinc bromide solution; pharmaceutical chemicals, such as hexamethyl disilazane, trimethyl chlorosilane, hexamethyl disiloxane, bromobenzene, and chloromethyl isopropyl carbonate; silanes comprising hexamethyl disilazane, trimethyl chlorosilane, and hexamethyl disiloxane; and agro chemicals. It provides contract development and manufacturing services. Chemcon Speciality Chemicals Limited was incorporated in 1988 and is based in Vadodara, India.
cscpl.com220
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: CHEMCON.NS
View MorePerformance Overview: CHEMCON.NS
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHEMCON.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHEMCON.NS
View MoreValuation Measures
Market Cap
7.62B
Enterprise Value
6.12B
Trailing P/E
32.63
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.63
Price/Book (mrq)
1.56
Enterprise Value/Revenue
2.91
Enterprise Value/EBITDA
13.34
Financial Highlights
Profitability and Income Statement
Profit Margin
11.04%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
2.12B
Net Income Avi to Common (ttm)
234.09M
Diluted EPS (ttm)
6.40
Balance Sheet and Cash Flow
Total Cash (mrq)
1.81B
Total Debt/Equity (mrq)
8.86%
Levered Free Cash Flow (ttm)
--